Danaher Corporation has agreed to a proposed $172.5 million securities class-action settlement to resolve claims that investors were misled about the outlook for the company’s bioprocessing business after the peak of the COVID-19 pandemic.
The case, Hawkins v. Danaher Corp., is pending in the U.S. District Court for the District of Columbia. The settlement has received preliminary approval but is not yet final. Danaher and the individual defendants deny wrongdoing and liability.
What Is the Danaher Securities Settlement?
The litigation was brought on behalf of investors who purchased or otherwise acquired Danaher common stock during the period from January 27, 2022 through October 23, 2023.
Plaintiffs alleged that Danaher and certain executives made materially false or misleading statements about the company’s business and prospects, particularly its bioprocessing operation, which supplies equipment used in the manufacture of biopharmaceutical vaccines and therapeutics.
The lawsuit alleged that Danaher shares traded at artificially inflated prices and that investors suffered losses when later disclosures allegedly revealed problems with the company’s outlook. The defendants dispute those allegations.
How Much Is the Settlement?
The proposed settlement creates a $172.5 million cash settlement fund.
After court-approved deductions for taxes, settlement administration expenses, attorneys’ fees, litigation expenses and other approved costs, the remaining net settlement fund will be distributed among eligible investors who submit valid claims.
Lead counsel may seek attorneys’ fees of up to one-third of the settlement fund, litigation expenses of up to $850,000, plus interest. The named plaintiffs may also seek aggregate awards of up to $70,000 for representing the class.
Who Is Eligible to File a Claim?
The settlement class generally includes people and entities that purchased or otherwise acquired Danaher common stock between January 27, 2022 and October 23, 2023, inclusive, and suffered damages.
Certain people and entities are excluded, including the defendants, specified family members, Danaher directors and officers during the class period, certain affiliated entities and investors who properly opt out.
Simply receiving a settlement notice does not guarantee a payment. Investors must meet the class definition and submit an acceptable Proof of Claim with the required transaction information and supporting documentation.
How Much Could Investors Receive?
The official settlement notice estimates an average distribution of approximately $1.13 per eligible Danaher common share before deductions for taxes, administration expenses, attorneys’ fees and other approved costs.
That figure is only an estimate. It is not a guaranteed payment of $1.13 for every share purchased.
An investor’s actual recovery will depend on the court-approved Plan of Allocation, including when shares were purchased or sold, applicable recognized losses and the total value of all valid claims submitted by other class members. Payments will be made on a pro rata basis from the net settlement fund.
What Is the Danaher Settlement Claim Deadline?
Investors who want to receive money from the settlement must submit a valid Proof of Claim no later than September 20, 2026.
Online claims must be received by 11:59 p.m. Eastern Time on September 20. Paper claim forms must be properly completed and postmarked by the same date.
Claimants should retain brokerage confirmations, account statements or other records showing their Danaher stock holdings, purchases and sales because supporting transaction documentation may be required.
Important August Deadlines
The deadline to request exclusion from the settlement is August 13, 2026. Investors who properly exclude themselves will not receive money from the settlement but may preserve the ability to pursue their own covered claims.
The deadline to object to the settlement, the proposed Plan of Allocation or the requested attorneys’ fees and expenses is August 20, 2026.
Class members who wish to ask to speak at the fairness hearing must also follow the court’s requirements by August 20.
When Is the Final Approval Hearing?
The court has scheduled the settlement fairness hearing for September 3, 2026 at 10:30 a.m. in Washington, D.C.
At the hearing, U.S. District Judge Amir H. Ali will consider whether the $172.5 million agreement is fair, reasonable and adequate and whether to approve the proposed allocation plan and fee requests.
The hearing date comes before the September 20 claim deadline. Even if the court grants final approval, payments will not necessarily be sent immediately. Claims must be processed, and any appeals may delay distribution.
Did Danaher Admit Wrongdoing?
No. The settlement does not represent an admission of liability.
Danaher and the other defendants deny making materially misleading statements, deny that Danaher stock was artificially inflated because of the alleged conduct and deny that class members suffered damages caused by any wrongdoing.
The parties reached the $172.5 million agreement after mediation in March 2026. According to the settlement notice, the resolution was intended to avoid the cost, risk and uncertainty of continued litigation.
What Should Danaher Investors Do Now?
Investors who bought Danaher common stock during the class period should review their brokerage records and determine whether they may qualify.
Those seeking payment must submit a valid claim by September 20, 2026. Investors considering opting out should pay particular attention to the earlier August 13 deadline.
For now, the Danaher agreement remains a proposed settlement. The court will consider final approval on September 3, 2026, and no individual payment amount can be guaranteed until valid claims are processed under the final approved Plan of Allocation.
